Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Pune Metro Line 3 opens as Modi lays Phase 2 foundation

    November 4, 2026

    MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

    November 3, 2026

    Sam Altman calls UAE most forward-looking country on AI

    November 3, 2026
    Malaya GazetteMalaya Gazette
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Malaya GazetteMalaya Gazette
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Facebook Twitter Pinterest LinkedIn Telegram Tumblr Email

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Chervon Names Thomas Scherer Vice President of Organizational Development – Sales, End User Marketing, and Service

    November 2, 2026

    Chervon Launches Advanced Momentum Program (AMP) to Hire & Develop the Next Generation of Leaders

    October 30, 2026

    U.S. Polo Assn. Executes Early on Europe’s Digital Product Passport Mandate

    October 29, 2026

    Chervon names Joel Petersheim as Vice President, End User Research and Sales – OPE Commercial USA

    October 26, 2026

    Chervon Names Devin Murray Director of Sales – Northern Division

    October 19, 2026

    Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update

    October 13, 2026
    Editor's Pick

    Pune Metro Line 3 opens as Modi lays Phase 2 foundation

    November 4, 2026

    MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

    November 3, 2026

    Sam Altman calls UAE most forward-looking country on AI

    November 3, 2026

    OpenAI deals bring frontier AI to ADNOC and Abu Dhabi Government

    November 3, 2026

    Indonesia’s non-oil exports drive $10.61bn trade surplus

    November 3, 2026

    Sheikh Mohamed receives Markus Söder to boost UAE-Bavaria ties

    November 3, 2026

    FirstRand joins African lenders eyeing Kenya bank acquisitions

    November 3, 2026

    Apple iPhone Duo sets a new benchmark for foldable design

    November 2, 2026
    © 2026 Malaya Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.